140 results match your criteria: "Radiofrequency Turbinate Reduction"
Radiol Case Rep
December 2024
Department of Radiology, Landeskrankenhaus Innsbruck- Medical University Innsbruck, Innsbruck, Austria.
Diagnostics (Basel)
August 2024
Department of ENT, Royal National ENT & Eastman Dental Hospitals, London WC1E 6DG, UK.
Background: Nasal obstruction is a frequent problem amongst patients with sleep-disordered breathing (SDB). Radiofrequency of the inferior turbinates (RFIT) is commonly utilized for inferior turbinate (IT) reduction but its effectiveness in SDB patients remains unproven. We aim to evaluate long-term objective and subjective nasal, olfactory and sleep outcomes following RFIT in SDB patients.
View Article and Find Full Text PDFPLoS One
July 2024
Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, Zurich, Switzerland.
Objective: The objective of this study was to retrospectively assess the effect of Radiofrequency Volumetric Tissue Reduction (RFVTR) on hypertrophic turbinates and clinical outcome in brachycephalic dogs when included in multi-level surgery (MLS).
Study Design: Clinical retrospective multicenter study.
Animals: 132 client-owned brachycephalic dogs.
J Med Econ
May 2024
Sacramento ENT, Sacramento, CA, USA.
Objective: To determine the economic impact of a minimally invasive temperature-controlled radiofrequency (TCRF) device for treating nasal airway obstruction (NAO).
Methods: A budget impact model was developed for two scenarios: a reference scenario of functional rhinoplasty surgery with concomitant septoplasty and inferior turbinate reduction (ITR) performed in the hospital outpatient department where TCRF is not an available treatment option and a new scenario consisting of in-office TCRF treatment of the nasal valve and ITR. A payor perspective was adopted with a hypothetical population plan size of one million members.
Rhinology
June 2024
Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VI, USA.
Background: Temperature-controlled radiofrequency (TCRF) device treatment of nasal valve dysfunction (NVD) was superior to a sham procedure control in reducing the symptoms of nasal airway obstruction (NAO) in this randomised controlled trial (RCT).
Methodology: Two-year outcomes for 108 patients actively treated in a prospective, multicenter, patient-blinded RCT were used to determine treatment effect durability and changes in medication/nasal dilator usage. A responder was defined as ≥ 20 reduction in NOSE score or 1 reduction in severity class.
Laryngoscope
April 2024
Pacific Neuroscience Institute, Santa Monica, California, U.S.A.
Background: Allergic rhinitis (AR) is a common condition that is frequently associated with atopic inferior turbinate hypertrophy (ITH) resulting in nasal obstruction. Current guidelines support the use of subcutaneous allergen immunotherapy (SCIT) when patients fail pharmacologic management. However, there is a lack of consensus regarding the role of inferior turbinate reduction (ITR), a treatment that we hypothesize is cost-effective compared with other available treatments.
View Article and Find Full Text PDFLaryngoscope Investig Otolaryngol
August 2023
Sinus and Nasal Specialists of Louisiana Baton Rouge Louisiana USA.
Background: The objective of this study was to evaluate long-term symptom improvements in patients with nasal airway obstruction (NAO) secondary to nasal valve collapse (NVC) following minimally invasive temperature-controlled radiofrequency (TCRF) treatment.
Methods: A prospective, single-arm, multicenter study in patients >18 years with NAO due to NVC. Inclusion criteria were response to nasal valve dilation (e.
Am J Rhinol Allergy
November 2023
Otorhinolaryngology, Mansoura University, Mansoura, Egypt.
Background: Variable surgical options are available for turbinate reduction. These options include total turbinectomy, partial turbinectomy, submucosal resection, laser surgery, cryosurgery, electrocautery, radiofrequency ablation, and turbinate out-fracture. However, there remains a lack of consensus for the preferred technique.
View Article and Find Full Text PDFActa Otorrinolaringol Esp (Engl Ed)
April 2023
Service of Otolaryngology, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.
Objective: Impaired nasal breathing is a common condition among pediatric patients, being rhinitis the most common cause. In recent years, turbinate surgery, mainly turbinate radiofrequency ablation (TRA), has increased in popularity amongst pediatric otolaryngologists and rhinologists as a safe and useful technique to address turbinate hypertrophy in pediatric patients. The present paper is designed with the aim of assessing the current worldwide clinical practice regarding turbinate surgery in pediatric patients.
View Article and Find Full Text PDFAm J Otolaryngol
June 2023
Department of Otolaryngology-Head and Neck Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel(1). Electronic address:
Objective: Radiofrequency ablation (RFA) reliefs nasal obstruction and improves quality of life (QoL) in patients suffering from inferior turbinate hypertrophy (ITH). A substantial benefit was noted among patients suffering from Rhinitis Medicamentosa (RM), enabling ending decongestant spray abuse. Our aim was to establish the benefit from RFA with respect to QoL in patients suffering from ITH, due to the presence of RM.
View Article and Find Full Text PDFInt Forum Allergy Rhinol
October 2023
Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background: Nasal airway obstruction (NAO) is a highly prevalent disorder. Septal swell body (SSB) hypertrophy is an often overlooked contributor to NAO. SSB treatment may relieve symptoms of NAO.
View Article and Find Full Text PDFCureus
January 2023
Department of Otolaryngology - Head and Neck Surgery, University of California Irvine, Orange, USA.
Inferior turbinate reduction procedures have been performed for decades. After significant evolution, turbinoplasty and other mucosal-sparing techniques have become the main method to successfully reduce turbinate hypertrophy. The debate of which technique produces the most effective and durable outcomes is ongoing.
View Article and Find Full Text PDFActa Otorhinolaryngol Ital
October 2022
Department of Otorhinolaryngology, Head and Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Eur Rev Med Pharmacol Sci
December 2022
Department of Otolaryngology and Head and Neck Surgery, Metaxas Cancer Hospital, Piraeus, Greece.
Objective: The objective of this study was to evaluate efficacy and safety of a Hypertonic Seawater Solution (2.3% NaCl) containing brown and blue-green Algae (HSS-A) in comparison to Isotonic Saline Solution (ISS) regarding the improvement of nasal breathing in patients that have undergone surgical correction of a deviated nasal septum and radiofrequency turbinate volume reduction.
Patients And Methods: A total of 101 individuals were enrolled in the study (HSS-A: 57; ISS: 44).
Am J Rhinol Allergy
January 2023
169841Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, SC, USA.
Background: Various surgical interventions exist for treatment of inferior turbinate hypertrophy (ITH). Though mucosal-sparing techniques are generally preferred, there is lack of consensus on the optimal technique.
Objective: This systematic review sought to evaluate the evidence for treatment of bilateral nasal obstruction via inferior turbinate reduction (ITR) and provide a meta-analysis of expected results of various techniques.
Sisli Etfal Hastan Tip Bul
September 2022
Department of Biostatistics, Eastern Mediterranean University Faculty of Medicine, Famagusta, Cyprus.
Objectives: Nasal obstruction (NO) is a very common complaint in the practice of otolaryngology. The cause of NO can be due to inferior turbinate hypertrophy (ITH), which may be a result of allergic rhinitis, hyperreactivity, hormonal causes, rhinitis medicamentosa or idiopathic. The most commonly used treatments today include local nasal or systemic corticosteroids, cauterization or microdebrider, or thermal ablation with radiofrequency, coblation or ablative laser (mainly carbon dioxide or diode lasers), and submucosal reduction.
View Article and Find Full Text PDFAm J Otolaryngol
December 2022
Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine, Suez Canal University, Ismailia, Egypt; Department of Otolaryngology, Queen's Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK. Electronic address:
Objective: To evaluate the effect of upper airway radiofrequency (RF) tissue reduction under local anesthesia (LA) in severe obstructive sleep apnea (OSA) patients using continuous positive airway pressure (CPAP) in order to improve their compliance and adherence.
Design: Thirty (30) patients were included in this randomized clinical trial, suffering from severe OSA seeking medical advice for better upper airway management while using CPAP. Multilevel RF tissue reduction at tongue base, soft palate and inferior nasal turbinates was done under LA in multiple sessions.
Braz J Otorhinolaryngol
March 2023
Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Objective: We aimed to evaluate the effect of radiofrequency turbinate reduction as an initial treatment on clinical improvement, inflammatory mediators, and remodeling process.
Methods: Between July 2018-February 2020, 32 patients with moderate-severe persistent AR were randomly divided into 2 groups. Intervention group received radiofrequency turbinate reduction followed by intranasal steroid and Antihistamine H-1 (AH-1), control group received intranasal steroid and AH-1.
Vestn Otorinolaringol
May 2022
Russian Medical Academy for Continuous Professional Education, Moscow, Russia.
The septal tubercle is considered to be a thickened area of the nasal septum, which is located above the lower nasal concha and in front of the middle nasal concha. Taking into account its histological structure and location in the distal segment of the internal nasal valve, it is located and structured for secretory function and vasoactive regulation of the respiratory air flow. These histologically rich tissues with glandular elements are well adapted to the possible dryness that occurs under the influence of intense air flow during breathing, and the existence of a certain number of venous sinusoids of the blood confirms the connection with part of the extensive vascular tissues in the nasal cavity.
View Article and Find Full Text PDFLaryngoscope Investig Otolaryngol
April 2022
Department of Otolaryngology-Head and Neck Surgery Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University Tel Aviv Israel.
Objectives: Inferior turbinate hypertrophy (ITH) and nasal septum deviation are leading causes of chronic nasal obstruction. Radiofrequency ablation (RFA) of hypertrophic inferior turbinates is effective for improving quality of life (QOL). We aim to assess QOL among patients with nasal obstruction associated with ITH and major deviated nasal septum.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
September 2022
Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, Catania, Italy.
Objective: Refractory inferior turbinate hypertrophy requires a surgical approach to address symptomatic complaints. Submucosal approaches demonstrated their efficacy in restoring respiratory function and respecting the nasal mucosa. Microdebrider-assisted turbinoplasty (MAT) tools effectively reduces the soft tissue, exploiting a very different principle from the kinetic energy of radiofrequency.
View Article and Find Full Text PDFJ Laryngol Otol
January 2022
Otorhinolaryngology Head and Neck Surgery Department, University of Health Sciences, Istanbul Training and Research Hospital, İstanbul, Turkey.
Objective: This study investigated whether inferior turbinate reduction combined with septoplasty improves patients' outcomes, as assessed by objective and subjective methods.
Methods: A single-centre, parallel-group, randomised, open-label trial was conducted at a tertiary hospital ENT clinic. Patients who underwent septoplasty were divided into two groups: group A underwent septoplasty with radiofrequency ablation; group B underwent only septoplasty.
Int J Environ Res Public Health
March 2021
Department of Otorhinolaryngology-Head & Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.
Surgical treatment of the inferior turbinates is required for hypertrophic inferior turbinates refractory to medical treatments. The main goal of surgical reduction of the inferior turbinate is to relieve the obstruction while preserving the function of the turbinate. There have been a variety of surgical techniques described and performed over the years.
View Article and Find Full Text PDFORL J Otorhinolaryngol Relat Spec
August 2021
Otorhinolaryngology Division, Department of Surgery, University of Eastern Piedmont "A. Avogadro", Novara, Italy.
Introduction: Radiofrequency turbinate volume reduction (RFTVR) is an effective treatment of inferior turbinate hypertrophy. RFTVR can reduce epithelial cell alterations in nasal mucosa. The aim of this observational study was to evaluate the effects of RFTVR on nasal obstruction and cytology, stratifying for different types of rhinitis.
View Article and Find Full Text PDFInt J Environ Res Public Health
January 2021
Bi.N.D. Department, University of Palermo, Via del Vespro, 129, 90127 Palermo, Italy.
(1) Background: Inferior turbinates' hypertrophy is often associated with Eustachian tube dysfunction (ETD); radiofrequency turbinate reduction (RTR) may provide a long-term improvement of nasal obstruction and ETD-related symptoms. (2) Aim: The study aimed to compare ETD in atopic and non-atopic patients before and after RTR and to investigate the correlation between tympanometry and Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7). (3) Methods: Ninety-seven patients, ranging from 33 to 68 years old, were screened by skin tests and divided into atopic (G1) and non-atopic (G2).
View Article and Find Full Text PDF